The role of cellular senescence in neurodegenerative diseases
Archives of Toxicology · 2024-08 · 98 (8) · 2393-2408
DOI: 10.1007/s00204-024-03768-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Toxicology, online erschienen am 15.05.2024. Verfasst von Yating Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science, Yangtze University, Jingzhou, 434025, China. Hauptthemen laut MEDLINE: Cellular Senescence, Neurodegenerative Diseases. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grantová Agentura České Republiky, Universidad de Granada, National Natural Science Foundation of China.
Abstract (Originalsprache)
Increasing evidence has revealed that cellular senescence drives NDs, including Alzheimer’s disease (AD) and Parkinson’s disease. Different senescent cell populations secrete senescence-associated secretory phenotypes (SASP), including matrix metalloproteinase-3, interleukin (IL)-1α, IL-6, and IL-8, which can harm adjacent microglia. Moreover, these cells possess high expression levels of senescence hallmarks (p16 and p21) and elevated senescence-associated β-galactosidase activity in in vitro and in vivo ND models. These senescence phenotypes contribute to the deposition of β-amyloid and tau-protein tangles. Selective clearance of senescent cells and SASP regulation by inhibiting p38/mitogen-activated protein kinase and nuclear factor kappa B signaling attenuate β-amyloid load and prevent tau-protein tangle deposition, thereby improving cognitive performance in AD mouse models. In addition, telomere shortening, a cellular senescence biomarker, is associated with increased ND risks. Telomere dysfunction causes cellular senescence, stimulating IL-6, tumor necrosis factor-α, and IL-1β secretions. The forced expression of telomerase activators prevents cellular senescence, yielding considerable neuroprotective effects. This review elucidates the mechanism of cellular senescence in ND pathogenesis, suggesting strategies to eliminate or restore senescent cells to a normal phenotype for treating such diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science, Yangtze University, Jingzhou, 434025, China.
- Department of Chemistry, Faculty of Science, University of Hradec Králové, 500 03, Hradec Králové, Czech Republic.
- Biomedical Research Center, University Hospital Hradec Kralove, 500 05, Hradec Kralove, Czech Republic.
- Andalusian Research Institute in Data Science and Computational Intelligence (DaSCI), University of Granada, Granada, Spain.
- College of Physical Education and Health, Chongqing College of International Business and Economics, Chongqing, 401520, China.
- Department of Chemistry and Biochemistry, Mendel University in Brno, 613 00, Brno, Czech Republic.
ORCID-Profile: Klaudia Jomova
Förderung
- Grantová Agentura České Republiky
- Universidad de Granada
- National Natural Science Foundation of China
- Ministerstvo Zdravotnictví Ceské Republiky
- Scientific Grant Agency
- Constantine the Philosopher University in Nitra
Zitieren
APA
Wang, Y., Kuca, K., You, L., Nepovimova, E., Heger, Z., Valko, M., Adam, V., Wu, Q., & Jomova, K. (2024). The role of cellular senescence in neurodegenerative diseases. Archives of Toxicology, 98(8), 2393-2408. https://doi.org/10.1007/s00204-024-03768-5
Vancouver
Wang Y, Kuca K, You L, Nepovimova E, Heger Z, Valko M, et al. The role of cellular senescence in neurodegenerative diseases. Archives of Toxicology. 2024;98(8):2393-2408. doi:10.1007/s00204-024-03768-5
BibTeX
@article{Wang2024,
author = {Wang, Yating and Kuca, Kamil and You, Li and Nepovimova, Eugenie and Heger, Zbynek and Valko, Marian and Adam, Vojtech and Wu, Qinghua and Jomova, Klaudia},
title = {The role of cellular senescence in neurodegenerative diseases},
journal = {Archives of Toxicology},
year = {2024},
volume = {98},
number = {8},
pages = {2393--2408},
doi = {10.1007/s00204-024-03768-5}
}
EUVIMED